Visual acuity, oncologic, and toxicity outcomes with (103)Pd vs. (125)I plaque treatment for choroidal melanoma

PURPOSE: To evaluate outcomes of choroidal melanoma patients treated with (125)I or (103)Pd plaque brachytherapy. METHODS AND MATERIALS: From 1993 to 2012, our institution treated 160 patients with (103)Pd (56.1%) and 125 patients with (125)I (43.9%) plaque brachytherapy. Tumor outcomes, visual acui...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Julkaisussa:Brachytherapy
Päätekijät: Patel, Kirtesh R., Prabhu, Roshan S., Switchenko, Jeffrey M., Chowdhary, Mudit, Craven, Caroline, Mendoza, Pia, Danish, Hasan, Grossniklaus, Hans E., Aaberg, Thomas M., Aaberg, Thomas, Reddy, Sahitya, Butker, Elizabeth, Bergstrom, Chris, Crocker, Ian R.
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: 2017
Aiheet:
Article
Linkit:https://ncbi.nlm.nih.gov/pmc/articles/PMC5586039/
https://ncbi.nlm.nih.gov/pubmed/28262517
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.brachy.2017.01.012
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!

Samankaltaisia teoksia